Percutaneous coronary intervention for coronary allograft vasculopathy with drug-eluting stent in Indian subcontinent: Issues in diagnosis and management
MS Alam, AS Singh, S Pavithran… - Annals of Pediatric …, 2020 - journals.lww.com
Coronary allograft vasculopathy fails to give a warning anginal pain due to denervation and
often presents with acute coronary syndrome, ventricular dysfunction, or sudden cardiac …
often presents with acute coronary syndrome, ventricular dysfunction, or sudden cardiac …
[HTML][HTML] Diagnosis and management of coronary allograft vasculopathy in children and adolescents
N Dedieu, G Greil, J Wong, M Fenton… - World Journal of …, 2014 - ncbi.nlm.nih.gov
Coronary allograft vasculopathy remains one of the leading causes of death beyond the first
year post transplant. As a result of denervation following transplantation, patients lack …
year post transplant. As a result of denervation following transplantation, patients lack …
[引用][C] Coronary interventional procedures in pediatric heart transplant recipients with cardiac allograft vasculopathy
RE Shaddy, JA Revenaugh, GS Orsmond… - American Journal of …, 2000 - ajconline.org
Cardiac allograft vasculopathy (CAV) is the main limiting factor to long-term survival after
pediatric heart transplantation. 1 Although the exact incidence of CAV after pediatric heart …
pediatric heart transplantation. 1 Although the exact incidence of CAV after pediatric heart …
Experience of percutaneous coronary intervention in the management of pediatric cardiac allograft vasculopathy
EBC Tham, AC Yeung, CWB Cheng… - The Journal of heart and …, 2005 - Elsevier
In a retrospective study, we examined the procedural success rate and the short-,
intermediate-, and long-term outcomes of coronary interventional procedures in children …
intermediate-, and long-term outcomes of coronary interventional procedures in children …
[HTML][HTML] Use of drug-coated balloon instead of drug-eluting stent for pediatric cardiac allograft vasculopathy
M Hirose, J Narita, K Hashimoto, R Ishii… - Annals of Pediatric …, 2023 - journals.lww.com
Cardiac allograft vasculopathy (CAV) sometimes leads to restenosis, even after
percutaneous transcatheter intervention. Recently, drug-coated balloons (DCBs) have been …
percutaneous transcatheter intervention. Recently, drug-coated balloons (DCBs) have been …
The presentation and diagnosis of coronary allograft vasculopathy in pediatric heart transplant recipients
A Jeewa, WJ Dreyer, DL Kearney… - Congenital heart …, 2012 - Wiley Online Library
One of the most important causes for long‐term graft failure in pediatric heart transplant
recipients is coronary allograft vasculopathy (CAV). Graft survival is approximately 50% at 5 …
recipients is coronary allograft vasculopathy (CAV). Graft survival is approximately 50% at 5 …
Comparative study of pediatric coronary allograft vasculopathy between single centers in North America and United Kingdom
M Fenton, A Mahmood, M Burch, J Simmonds… - Transplantation …, 2018 - Elsevier
Background Coronary allograft vasculopathy (CAV) is the leading cause of death after
pediatric heart transplantation from 1 year postoperation. Anecdotal evidence suggests a …
pediatric heart transplantation from 1 year postoperation. Anecdotal evidence suggests a …
Percutaneous Coronary Intervention in Pediatric Transplant Recipients-Delaying the Inevitable
MS Purlee, J Coppola, D Lopez-Colon… - The Journal of Heart …, 2024 - jhltonline.org
Purpose: Coronary allograft vasculopathy (CAV) is the leading cause of allograft failure in
pediatric patients. Atherosclerotic coronary disease is usually focal and is managed with …
pediatric patients. Atherosclerotic coronary disease is usually focal and is managed with …
Cardiac allograft vasculopathy in children—treatment challenges
SJ Kindel, E Pahl - Progress in Pediatric Cardiology, 2011 - Elsevier
Cardiomyopathy in children accounts for greater than 50% of the cases of end-stage cardiac
disease leading to heart transplantation in children. While early survival is excellent, late …
disease leading to heart transplantation in children. While early survival is excellent, late …
Effectiveness of percutaneous coronary intervention in cardiac allograft vasculopathy
AA Doshi, J Rogers, MJ Kern, PJ Hauptman - The American journal of …, 2004 - Elsevier
Twenty-five heart transplant recipients underwent 45 coronary interventions at a mean of
7.8±2.2 years from time of transplant. Periprocedural success was high, and there was a …
7.8±2.2 years from time of transplant. Periprocedural success was high, and there was a …
相关搜索
- coronary allograft vasculopathy issues in diagnosis
- allograft vasculopathy indian subcontinent
- indian subcontinent diagnosis and management
- percutaneous coronary intervention issues in diagnosis
- allograft vasculopathy treatment challenges
- allograft vasculopathy north america
- allograft vasculopathy diagnosis and management
- allograft vasculopathy presentation and diagnosis